The PIK3CA gene encodes a protein kinase that mediates signaling from insulin-like growth factor receptor IGF1R to the AKT pathway [45] (Fig. 4A), is frequently mutated in a number of cancers, and is itself the target of several chemotherapeutic agents. Here, PIK3CA is linked to cancer.